Sun Pharmaceutical Industries Limited, announced that it has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic Mesalamine...
NexImmune, Inc., Yale and JDRF have begun a two-year project to explore the use of NexImmune’s AIM nanoparticles in combination with an anti-CD3 mAb...
Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday when the immunotherapy drug failed to slow progression of...